Pooneh Alaei Taleghani 178 E 117 Street Apt. 4B New York, NY 10035 (404) 643-8641 [email protected]

EDUCATION: New York College of Podiatric Candidate for Doctor of Podiatric Medicine, May 2017 Bogomolets National Medical University, Ukraine Doctor of Medicine, M.D., June 1999

EXAMINATIONS: APMLE Part 2 CSPE, 2017 APMLE Part 2, 2017 APMLE Part 1, 2015

ECFMG Certification: 2009, , GA

USMLE Step 2 CS (Clinical Skills), 2009 USMLE Step 2 CK (Clinical Knowledge), 2009 USMLE Step 1, 2007

CLINICAL EXPERIENCE:

Endocrinology/Diabetes-Metabolism Harbin Rome, Volunteer September 2009-October 2009 Actively involved in examination of patients. Observed the diagnosis and management of a diverse range of patients.

North Fulton Regional Roswell, Georgia Volunteer 2007-2008 Attended doctors’ morning conferences, grand rounds and observed the diagnosis and management of diverse range of patient conditions both in and out-patients departments of Internal Medicine.

RESEARCH EXPERIENCE:

Emory University Hospital/Nuclear Medicine Division Atlanta, Georgia Research Associate 2010-2013 Worked on an NIH-funded project to evaluate F-18 FACBC, a novel imaging agent for assessing in- patient with recurrent prostate cancer. Worked on multiple clinical trials and patient-oriented research projects, including data collection, follow up, data analysis and serving as project supervisor. This included assisting in coordinating a multidisciplinary team of diagnostic imagers, scanning patients, following up on patient results and preparing manuscripts. Involved in preparation of interim reports. Participated in clinical conferences, including brain tumor, lung and prostate cancer.

Georgia Health Sciences University/TEDDY Study Atlanta, Georgia Research Associate 2009-2012 Worked at Georgia Health Sciences University, in the Atlanta Chapter of International TEDDY study, which is designed to study environmental triggers that may lead to the development of type 1 diabetes in genetically predisposed children. I was actively involved in conducting visits and various aspects of data management, including database organization. Preformed history and physical examination. Organized patient visits and follow-up appointments.

MEDICAL TRAINING:

Provincial University of Medical Sciences and Health Services Ghazvin, Iran Medical Intern 2002-2003 Completed internships in the departments of , Internal Medicine, Infectious Diseases and Psychiatry in a very busy metropolitan hospital. Actively participated in the diagnoses and management of patients. My internship consisted of working in both an out-patient and an in-patient clinic, as well as Emergency Department, ICU and Antenatal –Postnatal care, Labor unit, and Patient Admissions.

P.L. Shupyk National Medical Academy of Post Graduate Kiev, Ukraine Internal Medicine Resident 1999-2000 One-year residency in Department of and Venereal Diseases

PUBLICATIONS:

David M Schuster, Pooneh A Taleghani, Peter T Nieh, Viraj A Master, Rianot Amzat, Bital Savir- Baruch, Raghuveer K Halkar, Tim Fox, Adeboye O Osunkoya, Carlos S Moreno, Jonathon A Nye, Weiping Yu, Baowei Fei, Zhibo Wang, Zhengjia Chen, Mark M Goodman. Characterization of primary prostate carcinoma by anti-1-amino-2-[18F] -fluorocyclobutane-1-carboxylic acid (anti-3- [18F] FACBC) uptake. Am J Nucl Med Mol Imaging 2013;3(1):85-96

Rianot Amzat MD1, Pooneh Taleghani MD1, Daniel L Miller MD2, Jonathan J Beitler MD3, Leah M. Bellamy RN1, Jonathon A. Nye PhD1, Weiping Yu PhD1, Bital Savir-Baruch MD1, Adeboye O. Osunkoya MD4, Zhengjia Chen PhD5, William F Auffermann MD, PhD1, Mark M Goodman PhD1, David M Schuster MD1. Pilot study of the utility of the synthetic PET amino-acid radiotracer anti-1- amino-3-[18F] fluorocyclobutane-1-carboxylic acid for the non-invasive imaging of lung nodules (MIB-12-133-Jun-OA)

Amzat R, Taleghani P, Savir-Baruch B, Nieh PT, Master VA, Halkar RK, Lewis MM, Faurot M, Bellamy LM, Goodman MM, Schuster DM. Unusual presentations of metastatic prostate carcinoma as detected by anti-1-amino-3- [18F] FACBC PET-CT. Clinical Nuclear Medicine. September 2011 - Volume 36 - Issue 9 - pp 800-802

POSTERS AND PRESENTATIONS:

• Rianot Amzat1, Pooneh Alaei1, Bital Savir-Baruch1, Daniel Miller2, Jonathan Beitler3, Leah Bellamy1, Jonathon Nye1, Weiping Yu1, Mark Goodman1, David Schuster1; 1Radiology, Emory University, Atlanta, GA, 2Surgery, Emory University, Atlanta, GA, 3Radiation. (2011, June). Pilot study of the utility of anti-1-amino-3-[18F] fluorocyclobutane-1-carboxylic acid (anti-3-[18F] FACBC) PET-CT for the non-invasive imaging of lung nodules. Poster presented at: SNM 2011 annual meeting; Alpharetta, GA.

• Taleghani P, Amzat R, Osunkoya AO, Savir-Baruch B, Nieh PT, Master VA, Fei B, Fox T, Goodman MM, Schuster DM, Emory University, Atlanta, GA. Increased Expression of Ki-67 Correlates with Synthetic Amino Acid PET Radiotracer Uptake in Prostate Cancer. SNM 2012 annual meeting; FL.

• Taleghani P, Amzat R, Osunkoya AO, Savir-Baruch B, Nieh PT, Master VA, Fei B, Fox T, Goodman MM, Schuster DM, Emory University, Atlanta, GA. Synthetic amino acid PET in primary prostate carcinoma: correlation of pre-surgical imaging with radical prostatectomy specimens. SNM 2012 annual meeting; FL.

• Amzat R, Faraj B, Nye J, Taleghani P, Savir-Baruch B, Crowe R, Yu W, Bellamy M, Goodman MM, Schuster DM, Radiology, Emory University, Atlanta, GA. Variable Synthetic Amino Acid Radiotracer Urinary Excretion in Prostate Carcinoma. Poster presented at: SNM 2012 annual meeting; FL

• Amzat R, Taleghani P, Savir-Baruch B, Nieh PT, Master VA, Rossi P, Halkar RK, Goodman MM, Bowman FD, Schuster DM, Radiology, Emory University, Atlanta, GA. Extraprostatic recurrent prostate carcinoma detection with synthetic amino acid PET/CT surpasses imaging with 111Indium-capromab-pendetide plus diagnostic CT: SNM 2012 annual meeting; FL.

• Amzat R, Taleghani P, Nye J, Savir-Baruch B, Holder C, Olsen JJ, Crocker I, Voloschin A, Gavrikov V, Schuster DM, Radiology, Emory University, Atlanta, GA.Rb-82 Positron Emission Tomography for Post Therapy Brain Tumor Evaluation: SNM 2012 annual meeting; FL.

• David Schuster, Osunkoya Adeboye, Mark Goodman, Rianot Amzat, Pooneh Taleghani, Raghuveer Halkar, Bital Savir-Baruch, Andrew Young, Qiqin Yin-Goen, Shuntaro Oka, Carlos Moreno, Emory University, Atlanta, GA. Association of synthetic amino acid radiotracer uptake with mRNA expression of transporter genes in prostate carcinoma: RSN 2012 annual meeting; IL.

• Taleghani P, Odewole O, Savir-Baruch B, Nieh PT, Master VA, Jani AB, Goodman MM, Wang Z, Yu W, Schuster DM. Utility of anti-3-[18F] FACBC PET/CT to predict early biochemical failure following salvage cryotherapy for recurrent prostate cancer: SNM 2013 annual meeting Vancouver.

EXTRA-CURRICULAR ACTIVITIES: Class Representative, NYCPM Physicians for Human Rights Club 2016-2017 Class Representative, Public Health Club 2016-2017 Member, Forensic Podiatry Club 2013-Present Member, NYCPM Wound Care Club 2013-Present

HOBBIES AND INTERESTS: Skiing, Swimming, Running, Traveling, Zumba, Salsa dancing

LANGUAGES : Fluent Farsi (Persian), Proficiency in Russian